Abnormal Involuntary Movement Scale (AIMS)
0(min disability) - 42(max)
Loading...
0(min disability) - 42(max)
References
- D. Martino. Scales for Antipsychotic‐Associated Movement Disorders: Systematic Review, Critique, and Recommendations. Movement Disorders, 2023
- C. Correll. Measurement-based Diagnosis and Treatment for Tardive Dyskinesia.. The Journal of clinical psychiatry, 2021
- George A Keepers. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.. The American journal of psychiatry, 2020
- M. Stacy. Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference. Movement Disorders, 2019
- J. Kane. Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskinesia Assessment Workshop.. The Journal of clinical psychiatry, 2018
- T. Mentzel. Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis.. The Journal of clinical psychiatry, 2018
- R. Hauser. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.. The American journal of psychiatry, 2017
- Meredith K Ford. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index.. Annals of internal medicine, 2010